HugoScore hugoscore.org

Ambient scribe

Nabla

Nabla gives clinicians and healthcare organizations control over documentation, coding, and retention settings. Patient access, refusal, and correction depend on the deployment. Earlier consent and training assurances were not fully reverified in this pass.

AI-assisted draft Read full report Open directory

Published September 8, 2026 as an AI-assisted draft. The public report separates documented facts, agency judgments and unresolved questions.

40 /100 toward patient-directed
Agency posture Mixed
The question we ask Who does Nabla serve in this deployment?
Control Nabla's clinician-controlled ambient documentation, dictation, and coding workflows within provider organizations. Patient-impacting institutional AI.
Agency read Mixed
Vendor
Nabla Technologies
Who it serves
Institutional, clinician-mediated
Primary User
Clinicians and health systems
Control Model
Professional or institution-configured service. Patient controls depend on the deployment.
Patient Impact
Reviewed documentation may improve later understanding, but no direct patient mechanism to inspect or contest generated notes was established. Coding traceability for clinicians is not automatically patient-accessible.
Profile Status
AI-assisted draft
Last assessed
Sep 8, 2026
Review Confidence
Medium for institutional deployment and retention statements, low for patient-facing rights (AI-assisted draft)
AI / Model
OpenAI Codex / GPT-6
Human Review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Summary judgment · 40 out of 100 toward patient-directed

Nabla's clinician-controlled ambient documentation, dictation, and coding workflows within provider organizations. Patient-impacting institutional AI.

Mixed

Nabla gives clinicians and healthcare organizations control over documentation, coding, and retention settings. Patient access, refusal, and correction depend on the deployment. Earlier consent and training assurances were not fully reverified in this pass.

Patient agency

How this tool changes agency

Expands agency when

Reviewed documentation may improve later understanding, but no direct patient mechanism to inspect or contest generated notes was established. Coding traceability for clinicians is not automatically patient-accessible.

Limits agency when

Current consent guidance, no-training promise scope, local refusal alternatives, transcript access, and patient correction mechanisms.

Patient agency assessment

Who sets and changes the goal?

Patient authority

Clinicians and organizations choose the workflow and retention settings. A patient may benefit without controlling the note's purpose, final content, or coding. The evidence supports this allocation, not a judgment from vendor ownership.

What can the patient understand, question, or do?

Critical capacity

Reviewed documentation may improve later understanding, but no direct patient mechanism to inspect or contest generated notes was established. Coding traceability for clinicians is not automatically patient-accessible.

Can the patient evaluate the conditions of use?

Informed control

Concrete retention and hosting disclosures are useful. The baseline's no-training-on-notes and consent claims were not fully reverified and should remain dated claims rather than universal guarantees.

Text findings

Conditions of use

Published controls and their limits

Concrete retention and hosting disclosures are useful. The baseline's no-training-on-notes and consent claims were not fully reverified and should remain dated claims rather than universal guarantees.

What remains unknown?

Not tested or not established

Current consent guidance, no-training promise scope, local refusal alternatives, transcript access, and patient correction mechanisms.

Who evaluated this?

AI-assisted public-source draft

Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.

Sources checked

Source-specific findings and retrieval limitations are recorded in the full report.

Review provenance

Criteria

CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.

Reviewer

AI-assisted public-source reassessment prepared in OpenAI Codex.

AI / model

OpenAI Codex / GPT-6

Human review

Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Review date

2026-09-08

Limitations

Current consent guidance, no-training promise scope, local refusal alternatives, transcript access, and patient correction mechanisms. No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.

Review method

Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.

AI-assisted draft · Medium for institutional deployment and retention statements, low for patient-facing rights (AI-assisted draft)